Patents by Inventor Noëlle Gauvry

Noëlle Gauvry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sulfonylaminobenzamide compounds as anthelmintics
    Patent number: 10464889
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: November 5, 2019
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • Heterocyclyl-substituted cyclohexylsulfonamides as JAK inhibitors
    Patent number: 10370375
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: August 6, 2019
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • New Compounds
    Publication number: 20180346465
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis. Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 6, 2018
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS
    Publication number: 20180319741
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Application
    Filed: July 17, 2018
    Publication date: November 8, 2018
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • Compounds
    Patent number: 10059709
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: August 28, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • Sulfonylaminobenzamide compounds as anthelmintics
    Patent number: 10047040
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: August 14, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • Diaryl isoxazoline compound
    Patent number: 10040785
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: August 7, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • DIARYL ISOXAZOLINE COMPOUND
    Publication number: 20180155331
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Application
    Filed: February 5, 2018
    Publication date: June 7, 2018
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • Diaryl isoxazoline compound
    Patent number: 9920037
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: March 20, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • Compounds for the control of endoparasites
    Patent number: 9820488
    Abstract: The invention relates to compounds of the general formula (I) wherein the variable have the meanings as indicated in the claims, or a physiologically acceptable salt thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites in warm-blooded animals.
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: November 21, 2017
    Assignee: ELANCO TIERGESUNDHEIT AG
    Inventors: Noëlle Gauvry, François Pautrat
  • DIARYL ISOXAZOLINE COMPOUND
    Publication number: 20170240536
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Application
    Filed: November 6, 2015
    Publication date: August 24, 2017
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS
    Publication number: 20170226053
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Application
    Filed: August 27, 2015
    Publication date: August 10, 2017
    Applicant: Novartis Tiergesundheit AG
    Inventors: Noelle Gauvry, Chouaib Tahtaoui
  • Sulfonylaminobenzamide compounds
    Patent number: 9714219
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: July 25, 2017
    Assignee: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Noelle Gauvry, Francois Pautrat, Jean-Luc Perret, Chouaib Tahtaoui
  • Substituted azines as pesticides
    Patent number: 9580404
    Abstract: The invention relates to compounds of the general formula (I), wherein the variable have the meanings as indicated in the claims, or a physiologically acceptable salt thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites in warm-blooded animals.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: February 28, 2017
    Assignee: Novartis Tiergesundheit AG
    Inventors: Noelle Gauvry, Francois Pautrat
  • New Compounds
    Publication number: 20170050965
    Abstract: The invention relates to a compound of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful as therapeutic agent for organ transplants, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes and complications from diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, inflammatory bowel diseases, Crohn's disease, Alzheimer's disease, leukemia, osteoarthritis, control of pruritus, chronic respiratory disease or keratoconjunctivitis in mammals.
    Type: Application
    Filed: March 25, 2015
    Publication date: February 23, 2017
    Inventors: Noelle Gauvry, Chouaib Tahtaoui, Pascal Furet, Pierre Ducray
  • (Hetero) arylacrylamides for the control of ectoparasites
    Patent number: 9491941
    Abstract: The present invention relates to new compounds of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on vertebrates.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: November 15, 2016
    Assignee: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Emilie Dupont, Noelle Gauvry, Steve Nanchen, Chikako Ogawa, Chouaib Tahtaoui
  • SUBSTITUTED AZINES AS PESTICIDES
    Publication number: 20160257665
    Abstract: The invention relates to compounds of the general formula (I), wherein the variable have the meanings as indicated in the claims, or a physiologically acceptable salt thereof. The active ingredients have advantageous pesticidal properties.
    Type: Application
    Filed: May 17, 2016
    Publication date: September 8, 2016
    Inventors: Noelle Gauvry, Francois Pautrat
  • NEW COMPOUNDS
    Publication number: 20160251335
    Abstract: The invention relates to compounds of the general formula (I) wherein the variable have the meanings as indicated in the claims, or a physiologically acceptable salt thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites in warm-blooded animals.
    Type: Application
    Filed: November 14, 2014
    Publication date: September 1, 2016
    Inventors: Noëlle GAUVRY, François PAUTRAT
  • NEW SULFONYLAMINOBENZAMIDE COMPOUNDS
    Publication number: 20160221937
    Abstract: The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.
    Type: Application
    Filed: June 10, 2015
    Publication date: August 4, 2016
    Inventors: Noelle Gauvry, Francois Pautrat, Jean-Luc Perret, Chouaib Tahtaoui
  • Substituted azines as pesticides
    Patent number: 9357782
    Abstract: The invention relates to compounds of the general formula (I), wherein the variable have the meanings as indicated in the claims, or a physiologically acceptable salt thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling endoparasites in warm-blooded animals.
    Type: Grant
    Filed: August 6, 2013
    Date of Patent: June 7, 2016
    Assignee: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Noelle Gauvry, Francois Pautrat